We are executive search and leadership development specialists working to build a better future. As advisors and consultants to companies at the cutting edge of Health, Science, and Technology, we are united by our mission to build teams that change the world. Operating uniquely as one global team, we have honed our expertise, platform, and data for over two decades, working across three continents, and in 40 countries. Applying what we learn through our work with boards, leadership teams, and investors in the world’s most innovative companies, we bring together and develop the right people at the right time to propel them to achieve their worthwhile goals.
The Coulter Partners team is made up of 110 experts, working in 40 countries, holding 250,000 conversations with industry leaders each year. Together we channel data and learning to the benefit of our clients. We are a diverse group of experts with backgrounds ranging from science and technology, to the arts, finance, and more. Our reward system is designed to drive one-team behaviors and we work together seamlessly to combine industry experience and global insight with our passion for progress. Our team understands and is up to date with the challenges you face and the opportunities your business can maximize. This means we can find and develop exceptional individuals to drive you forward.
Our network is carefully curated and gives us access to leaders who can guide science, technology and innovation-driven companies through all stages of growth and evolution. Our executive search is an end-to-end process, underpinned by rigorous data and analytics from our dedicated Business Intelligence function and CP:Net™, our proprietary AI-driven candidate and company database. Our Board Advisory brings over two decades’ experience in building, advising and evolving boards for private and public companies. We understand what value a board can bring and how to evaluate its suitability for the stage of the business and the 3–5-year plan. We also provide leadership advisory at every step of the way. We have a network of mentors and advisors that bring the next level of insight to your organization, to build teams that change the world.
Life sciences recruiting specialist Coulter Partners has assisted in the recruitment of Jonathan Sadeh as executive vice president, chief medical officer and head of R&D at NYSE-traded Bausch Health Companies Inc. Antonietta Baffa, Lilyana Chukova, and Nona Footz led the assignment. “We are delighted to welcome Jonathan as our new head of research and development,” said Thomas J. Appio,
Life sciences recruiting specialist Coulter Partners has assisted in the recruitment of Michael Shih as the new CEO of NeoPhore in London. Leading the assignment were Chris Palatucci, Clare Evans-Argent, Gabrielle Banzon, and Kay Wardle. The appointment follows the close of the company’s oversubscribed series B financing. The financing and new appointment of the CEO strengthen NeoPhore’s
Life sciences recruiting specialist Coulter Partners has helped to recruit John Baker as chief executive officer and Jason Brown as chief business officer of biotechnology company IMU Biosciences. Founder and past CEO Adam Laing will assume the roles of president and chief scientific officer. “I am incredibly proud of what the IMU team has achieved to date,” said
Life sciences recruiting specialist Coulter Partners has assisted in the recruitment of Lloyd Diamond as the new CEO of Nitinotes Surgical in Caesarea, Israel. He succeeds Raz Bar-On, who will continue as general manager. “We are thrilled to welcome Lloyd to lead Nitinotes into its next chapter of innovation and growth,” said John Barr, chairman of the
Coulter Partners successfully completed a search assignment for Alethio Therapeutics – formerly known as Alethiomics – and is pleased to announce the placement of Dr. Rohit Batta as Chief Executive Officer. Alethio Therapeutics is a biotech company advancing therapies designed to help people with Myeloproliferative Neoplasms (MPNs) live longer, healthier, and more fulfilling lives. Backed by
Coulter Partners announces a further strengthening of its senior leadership with Ian Coyne joining the Managing Partners group. In addition to this strategic leadership expansion, the firm further refined the structure of its Senior Leadership team, with Joe Coulter assuming a new role as Chief Business Officer (CBO) and Charlotte James being promoted to Chief Operating Officer (COO). Ian Coyne, who joined Coulter Partners in 2019, is invited
Coulter Partners successfully completed a search assignment for Vicore Pharma Holding AB (STO: VICO) and is pleased to announce the placement of Katrine Husum as R&D Senior Project Director. Vicore Pharma is a clinical-stage pharmaceutical company focused on developing treatments for severe respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). The company is developing a new class of drugs with
Coulter Partners successfully completed a search assignment for Proveca Ltd (“Proveca”) and is pleased to announce the placement of Gregory Reinaud as Chief Operating Officer (COO). Proveca is a specialist pharmaceutical company dedicated to providing licensed medicines for children. The Company develops and licenses medicines for children with long-term, chronic conditions, addressing the significant issue
Coulter Partners successfully completed a search assignment for Parkinson’s UK and is pleased to announce the placement of Dr. Lynsey Bilsland as Managing Director of Parkinson’s Virtual Biotech. The Parkinson’s Virtual Biotech is the global drug discovery and development program of Parkinson’s UK. Driven by the Parkinson’s community, it is investing strategically to deliver crucial life-changing therapies faster. Dr. Bilsland brings extensive
News
Top hires for Q3-2025
Top hires for Q2-2025
Coulter Partners: Fostering Digital Health connections on the Seine
Coulter Partners at BIA Women in Biotech: Driving diversity in Life Sciences leadership
Coulter Partners joins key discussion on HealthTech Boards at NHS Innovation Accelerator day
Coulter Partners at the BIA Life Science Leadership Summit: Fostering Board Excellence and UK Biotech Growth!
Coulter Partners attends LabCentral’s Luminescence: Rise & Fund event in Boston, MA
Leadership in MedTech: Key insights from our Paris roundtable
Coulter Partners co-hosts premier UK HealthTech Super Connector event
Coulter Partners attends Bio€quity Europe in Bruges, Belgium
Coulter Partners attends Danish Biotech Spring Gala
Top hires for VC & PE portfolio companies Q1-2025
Evolution Italy: Life Science leaders gather for insightful discussions
Coulter Partners at BioCapital Europe 2025: Innovation and optimism reign
BioInnovation Institute Breakfast Seminar Health Tech Ecosystem – Copenhagen
BIA Gala Dinner 2025
Top hires for VC & PE portfolio companies Q4-2024
Top global hires for large-cap, mid-cap and public companies H2-2024